fda semaglutide shortage lawsuit Warns on Certain Forms of Compounded compounded semaglutide lawsuit news today

The European Medicines Agency (EMA) continues to monitor the safety profile of GLP-1 receptor agonists

Discard any unused portion of an opened vial, as the formulation does not contain a preservative

These findings indicate that treatment with Dihexa improves cognition in APP/PS1 mice [1]

The Bottom Line Up Front It's crucial to understand that while the risk of developing pancreatitis while on a GLP-1 medication is considered very small , it is a recognized and potentially serious side effect

NAION (Vision Loss): Recent litigations focus heavily on non-arteritic anterior ischemic optic neuropathy (NAION), often described as an eye stroke